Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Company profile
Website
CEO
Robert J. Palmisano
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
Tornier B.V., Tornier N.V.
SEC CIK
Corporate docs
IRS number
980509600
Latest filings (excl ownership)
15-12B
Securities registration termination
23 Nov 20
EFFECT
Notice of effectiveness
18 Nov 20
8-K
Entry into a Material Definitive Agreement
16 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Nov 20
Transcripts
Earnings call transcript
2019 Q2
8 Aug 19
Earnings call transcript
2019 Q1
9 May 19
Earnings call transcript
2018 Q4
26 Feb 19
Earnings call transcript
2018 Q3
10 Nov 18
Earnings call transcript
2018 Q2
8 Aug 18
Earnings call transcript
2018 Q1
9 May 18
Earnings call transcript
2017 Q4
27 Feb 18
Earnings call transcript
2017 Q3
1 Nov 17
Latest ownership filings
4
Jennifer S. Walker
13 Nov 20
4
Kevin C. Smith
13 Nov 20
4
Julie D. Dewey
13 Nov 20
4
Patrick Fisher
13 Nov 20
4
Julie Andrews
13 Nov 20
4
Wright Medical / Medical Group N.V. Wright ownership change
13 Nov 20
4
Lance A Berry
13 Nov 20
4
Steven P. Wallace
13 Nov 20
4
ELIZABETH H WEATHERMAN
13 Nov 20
4
Kevin D Cordell
13 Nov 20
Financial summary
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 141.55 mm | 141.55 mm | 141.55 mm | 141.55 mm | 141.55 mm | 141.55 mm |
Cash burn (monthly) | (no burn) | 752.08 k | (no burn) | 3.06 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 32.37 mm | n/a | 131.80 mm | n/a | n/a |
Cash remaining | n/a | 109.18 mm | n/a | 9.75 mm | n/a | n/a |
Runway (months of cash) | n/a | 145.2 | n/a | 3.2 | n/a | n/a |
Institutional ownership, Q1 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|